However, in accordance to our data with respect to intraglomerular hemodynamics (see above), there was only a numerical reduction of FF after combined E+L treatment, without reaching significance or showing a clear trend-level, hence not supporting a modulation of presumed hyperfiltration status at single-nephron level.
← all excerpts
Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine.
1
—
—